KRAS and neoplasm: Next, to further clarify the biological implications of the KRAS mutation subtype, we performed ssGSEA/post-transcriptional modification (PTM) and Metascape analyses in the KM1 and KM2 tumor subsets at the RNA, protein, and phosphoprotein levels.